Characterization of the Immune Response Induced by Rhabdovirus-Infected Leukemia Cell Vaccines
Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are blood cancers that are often treated with stem cell transplantation (SCT). Since SCT treatments have variable success, especially in adults with AML whose disease frequently relapses, novel and more effective solutions must be c...
Main Author: | Scut, Elena |
---|---|
Other Authors: | Kekre, Natasha |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2020
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/40944 http://dx.doi.org/10.20381/ruor-25170 |
Similar Items
-
Characterization of the Anti-Tumour Immune Response Following Treatment with an Infected Leukemia Cell Vaccine
by: Dempster, Holly
Published: (2018) -
Exploiting the Antitumor Immune Response Using IL-12 Armed Oncolytic MG1 Virus In An Infected Cell Vaccine
by: Alkayyal, Almohanad
Published: (2016) -
Discovery and Application of Neoepitopes in an Oncolytic Rhabdovirus Vaccine Approach to Treat Glioblastoma Multiforme
by: Jilesen, Zachary Keavin
Published: (2019) -
An Interleukin-12-Expressing Oncolytic-Virus Infected Autologous Tumor Cell Vaccine Generates Potent Anti-Tumor Immune Responses
by: Khan, Sarwat Tahsin
Published: (2018) -
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy
by: Fanny Tzelepis, et al.
Published: (2020-12-01)